## SJM: The J.M. Smucker Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -5.4% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (57% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($95.94)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Is Smucker’s Sharper 2026 Guidance And Completed Buyback Altering The Investment Case For J. M. Smucker (SJM)?**
- Source: Simply Wall Street | 20251208T011423 | Somewhat-Bullish | Relevance: 99%
- J. M. Smucker recently reported improved second-quarter 2026 results, with net sales and income rising, and stronger EPS. Management also tightened its full-year 2026 net sales growth outlook and completed a significant share repurchase program. This leads to a sharper focus on coffee pricing as a key catalyst and increased input costs as a risk, especially with the ongoing integration of acquisitions like Hostess.

**2. First Trust Advisors LP Has $53.57 Million Stake in The J. M. Smucker Company $SJM**
- Source: MarketBeat | 20251208T093423 | Neutral | Relevance: 98%
-  First Trust Advisors LP reduced its stake in The J. M. Smucker Company (SJM) by 15.2% during Q2, holding 545,493 shares valued at $53.57 million. Several other institutional investors also adjusted their positions, with institutional ownership of the company's stock currently at 81.66%. The company reported Q2 earnings per share of $2.10, missing analyst estimates, and announced a quarterly dividend of $1.10 per share.

**3. Morgan Stanley Trims JM Smucker (SJM) Price Target, Maintains Overweight Rating**
- Source: MSN | 20251206T000907 | Neutral | Relevance: 98%
- Morgan Stanley has adjusted its price target for JM Smucker (SJM) downward. Despite the revised price target, the firm has chosen to maintain its Overweight rating on the stock. This indicates a continued positive outlook for SJM by Morgan Stanley, albeit with a slightly moderated valuation expectation.

**4. Marshall Wace LLP Makes New Investment in The J. M. Smucker Company $SJM**
- Source: MarketBeat | 20251208T113146 | Neutral | Relevance: 98%
-  Marshall Wace LLP has initiated a significant new stake in The J. M. Smucker Company (NYSE:SJM) by purchasing over 371,000 shares valued at approximately $36.43 million, representing 0.35% of the company. This investment comes amidst mixed analyst sentiment with a consensus "Hold" rating and recent insider selling by CFO Tucker H. Marshall. The company reported slightly missed quarterly EPS but provided a positive FY2026 guidance and pays a 4.4% dividend.

**5. When copycats cross the line: What Smucker’s lawsuit means for private-label products**
- Source: FoodBev Media | 20251208T133542 | Neutral | Relevance: 97%
-  Smucker's lawsuit against Trader Joe's regarding its "Crustless" peanut butter and jelly sandwiches highlights a growing legal battle over private-label duplications. This case, alongside Mondelēz International's suit against Aldi, focuses on intellectual property infringements related to both packaging and product shape. The outcome could significantly impact how private-label products mimic national brands in the grocery sector.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | JP Morgan | $121 | $122 | -1% |
| 2025-11-26 | UBS | $117 | $120 | -2% |
| 2025-11-26 | Morgan Stanley | $115 | $118 | -3% |
| 2025-11-26 | Stifel | $110 | $115 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | JP Morgan | main | Overweight |
| 2025-11-26 | UBS | main | Buy |
| 2025-11-26 | Morgan Stanley | main | Overweight |
| 2025-11-26 | Stifel | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 4 ($1.92M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-3.1%)
- Blackrock Inc.: 8.1% (+1.4%)
- State Street Corpora: 6.7% (-3.0%)
- Barclays Plc: 3.7% (+386.9%)
- Geode Capital Manage: 2.7% (+1.7%)

### Key Risks

1. Long-term trend broken: trading 7.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Analyst sentiment negative (4 target cuts vs 1 raises). Insider selling cluster ($1.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.7B |
| Beta | 0.21 |
| 52W Range | $93.30 - $121.48 |
| Short Interest | 7.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 12.6 |
| Current P/E | 11.2 |
| YoY Growth | -11.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -5.4% (minimal 5-day change). Below STRENGTH zone by 9.4pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.1%) - potential reversal signal. AM_20 at -3.4% indicates price below own 20MA trend. Underperforming sector by 3.4pp, stock-specific weakness. Below SMA200 (0.93x), long-term trend not supportive. RSI neutral at 41. Volume at 57% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.40% (CS: 12) | Weak |
| RSI_14 | 41.1 | Neutral |
| MACD Histogram | -0.50 | Bearish |
| vs SMA20 | 0.964x | Below |
| vs SMA50 | 0.961x | Below |
| vs SMA200 | 0.928x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $100.68
- **Stop Loss:** $95.94 (4.7% risk)
- **Target:** $105.42 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 105
- **Position Value:** $10,571.40
- **Portfolio %:** 10.57%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-26 (Est: $2.26)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.10 | $2.10 | -0.0% |
| 2025Q3 | $1.93 | $1.90 | -1.4% |
| 2025Q2 | $2.25 | $2.31 | +2.8% |
| 2025Q1 | $2.37 | $2.61 | +10.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*